Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma
Luye Pharma of Yantai will purchase the 42% of Beijing Jialin Pharma it does not already own for $390 million. In August, Luye announced it would pay $599 million to acquire an initial 58% stake in Beijing Jialin, a company focused on cardiovascular and cancer drugs. In 2013, Beijing Jialin reported $180 million of revenue and net profit of $41 million. The total purchase price of $989 million is 24 times Jialin's 2013 profit.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.